ArticlePDF Available

Russula subnigricans Poisoning: From Gastrointestinal Symptoms to Rhabdomyolysis

Authors:

Abstract and Figures

Wild mushroom poisoning is often reported to cause acute liver or renal failure. However, acute rhabdomyolysis caused by wild mushroom poisoning has rarely been reported. We describe 7 patients of 1 family with Russula subnigricans Hongo poisoning. Their clinical manifestations varied from gastrointestinal symptoms to rhabdomyolysis, with 1 fatality. Our report provides supporting evidence that rhabdomyolysis may result from ingestion of R subnigricans mushrooms. A key to survival for patients with rhabdomyolysis caused by R subnigricans poisoning may be early recognition and intensive supportive care. Copyright © 2015 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.
Content may be subject to copyright.
WILDERNESS & ENVIRONMENTAL MEDICINE, 26, 380383 (2015)
CASE REPORT
Russula subnigricans Poisoning: From Gastrointestinal
Symptoms to Rhabdomyolysis
Shide Lin, MD; Maoyuan Mu, MM; Fangwan Yang, MM; Chunfei Yang, BSM
From the Department of Infectious Diseases, First Afliated Hospital of Zunyi Medical College, Zunyi, China (Dr Lin, Ms. Mu, and Mr F Yang);
and the Department of Internal Medicine, Peoples Hospital of Dejiang County, Dejiang, China (Mr C Yang).
Wild mushroom poisoning is often reported to cause acute liver or renal failure. However, acute
rhabdomyolysis caused by wild mushroom poisoning has rarely been reported. We describe 7 patients
of 1 family with Russula subnigricans Hongo poisoning. Their clinical manifestations varied from
gastrointestinal symptoms to rhabdomyolysis, with 1 fatality. Our report provides supporting evidence
that rhabdomyolysis may result from ingestion of R subnigricans mushrooms. A key to survival for
patients with rhabdomyolysis caused by R subnigricans poisoning may be early recognition and
intensive supportive care.
Key words: rhabdomyolysis, mushroom poisoning, Russula subnigricans, basidiomycete
Introduction
More than 2000 species of mushrooms found worldwide
are safe for human consumption, but there are also many
wild mushrooms that are toxic.
1
In China, edible mush-
rooms are readily available, inexpensive, and widely
consumed. Wild poisonous mushrooms may closely
resemble those that are edible and can be accidentally
ingested. Thus, outbreaks of wild mushroom poisoning
frequently occur in rural areas of China. From 1994 to
2012, the Chinese Center for Disease Control and
Prevention (CDC) reported 311 mushroom poisoning
events, with 1954 poisoning cases and 409 deaths.
2
Poisoning caused by the death capmushroom
Amanita phalloides has often been reported.
3
It is one
of the most toxic wild mushrooms in the world and can
cause acute liver failure and death in humans.
4,5
Cortinarius species have also been reported to cause
renal failure.
6,7
However, wild mushroom poisoning as
the cause of rhabdomyolysis has rarely been reported.
We describe a family of 7 patients poisoned by Russula
subnigricans Hongo wild mushrooms. Their clinical
manifestations varied from gastrointestinal symptoms
to rhabdomyolysis, with 1 fatality.
CASE REPORTS
Seven people from 1 family, including 4 women (age
range, 1551 years) and 3 men (age range, 1858 years),
ingested wild mushrooms on July 19, 2013. They were
hospitalized on July 20, 2013, with nausea, vomiting,
diarrhea, and dizziness. One patient had picked wild
mushrooms in the forests of Shiqian county, Guizhou
province, China, and all 7 patients had consumed 10 to
100 g of the mushrooms after cooking them at home,
20 hours before admission. At admission, all patients had
fatigue and muscle weakness and 5 patients had myalgia,
mainly in the upper parts of the legs. No fever was noted.
All patients had normal blood pressure. The ndings on
physical examination, which included cardiopulmonary
auscultation and a neurologic assessment, were
unremarkable.
On admission, initial screening tests showed serum
creatine kinase (CK) levels were elevated in 6 patients
(Table). The median levels of CK, aspartate amino-
transferase (AST), and alanine aminotransferase (ALT)
were 2063 U/L (range, 12666,950 U/L; normal, 38174
U/L), 151 U/L (range, 24636 U/L; normal, o40 U/L),
and 32 U/L (range, 12178 U/L; normal, o50 U/L),
respectively. Coagulation tests and serum creatinine
(SCr) levels were normal. Three patients had hypok-
alemia (range, 3.023.41 mmol/L; normal, 3.505.30
mmol/L), and 2 patients had hypocalcemia (range, 2.06
2.16 mmol/L; normal, 2.202.65 mmol/L).
Corresponding author: Shide Lin, MD, Department of Infectious
Diseases, Zunyi Medical College, 201 Dalian Street, Zunyi, Guizhou
563003, China (e-mail: linshide6@hotmail.com).
Because 6 patients had elevated serum CK levels,
rhabdomyolysis and acute myocarditis were suspected.
However, the absence of abnormalities on electrocardio-
gram and echocardiography ruled out a cardiac origin
for the increased serum levels of CK. Initially, gastric
lavage was performed in all patients, together with uid
replacement. The patients were also treated with pen-
icillin G (400,000500,000 U/kg per day, intravenous)
and silybin (silibinin; 1020 mg/kg per day, oral).
The serum CK values in 4 of the 6 patients who
survived further increased on the day after admission
(Figure 1), their weakness worsened, and production
of dark urine was observed; and hypokalemia (range,
3.233.43 mmol/L) and hypocalcemia (range, 1.882.16
mmol/L) were found. These 4 patients were subse-
quently treated with hemodialysis to prevent acute
kidney injury. From the third day, their serum CK
levels gradually declined to the standard range, and
they experienced progressive recovery of muscle
strength.
In the 1 patient who died, weakness and myalgia
worsened during the rst 12 hours after admission, and
dark urine was also observed. Arterial blood gas values
while breathing 50% inspired oxygen were a pH of 7.26,
PO
2
of 97.54 mm Hg, PCO
2
of 44.78 mm Hg, and HCO
3
of 20.52 mmol/L; hypokalemia (3.02 mmol/L) was also
found. The patient was admitted to the intensive care
unit 6 hours after admission and treated with hemodial-
ysis on the second day after admission. However, on the
third day after admission, the patient had hyperthermia (a
temperature of up to 401C) and signs of severe dehy-
dration and acute myocarditis, including cardiac arrhyth-
mia, cardiovascular collapse, and widening of the QRS
complex. His serum CK level further increased and
reached 228,750 U/L, and serum calcium decreased to
1.51 mmol/L. Elevated levels of blood urea nitrogen
(53.69 mg/dL) and SCr (2.73 mg/dL) indicated renal
dysfunction (Figure 2). Fever was treated with physical
cooling methods, including strategic ice packs. Despite
intensive physiological care, including continuous veno-
venous hemoltration, intravenous uid, and bicarbonate
administration, the patient died on the fourth day after
admission. Autopsy was denied. During hospitalization,
although his serum ALT and aspartate aminotransferase
levels also increased, the serum total bilirubin and
coagulation tests remained normal.
Table. Background data and laboratory ndings of 7 patients with Russula subnigricans poisoning at the time of admission
Normal range Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7
*
Age, y 58 51 14 15 18 15 50
Sex MFFFMFM
ALT, U/L o40 178
54
15 27 12 32 51
CK, U/L 38174 31,590
66,950
2063
285
281
126 10,610
sCr, mg/dL 0.461.23 0.91 0.80 0.62 0.71 1.09 0.71 0.84
Tbil, μmol/L o22 16.6 11.3 19.5 11.4 17 12.9 19.8
ALT, alanine aminotransferase; CK, creatine kinase; sCr, serum creatinine; Tbil, total bilirubin.
n
The only patient to die; all other patients recovered.
Above normal limits.
0
20000
40000
60000
80000
100000
12345678910
CK (U/L)
Days after admission
patient 1
patient 2
patient 3
patient 4
patient 5
Figure 1. Serum creatine kinase (CK) levels in 5 patients who
survived during hospitalization.
0
0.5
1
1.5
2
2.5
3
0
50000
100000
150000
200000
250000
123
sCr (mg/dl)
CK (U/L)
Days after admission
CK
sCr
Figure 2. Serum creatine kinase (CK) and serum creatinine (sCr)
levels in the patient who died during hospitalization.
Rhabdomyolysis by Russula Mushroom 381
MUSHROOM IDENTIFICATION
Mushroom samples (Figure 3) were sent to our hospital
and identied as R subnigricans Hongo by a mycologist
from the Mushroom Research Institute of Shanghai
Academy of Agricultural Science.
Discussion
The world geographic distribution of R subnigricans is
not completely dened, although it has been identied in
the United States, China, and Japan. In China, R
subnigricans grows in several southern provinces. The
mushrooms are often confused with those of the similar
species Russula nigricans, which is less poisonous. The
differentiating features of these 2 species are that the
esh of R subnigricans is white but turns red when
damaged. The esh of R nigricans is initially white, then
red, and turns black when damaged.
8
Rhabdomyolysis is a clinical syndrome caused by
severe injury to skeletal muscle, leading to the release of
the intracellular muscle constituents into the circulation
and extracellular uid. The most common cause of
rhabdomyolysis is muscular trauma; the other causes of
rhabdomyolysis include medications, hyperthermia, tox-
ins, infections, and endocrinopathies,
9
but neither muscle
ischemia nor unconsciousness was noted before the
onset of symptoms in our patients. Drug intoxication
could also be ruled out because none of the patients had
taken any drugs within 1 month before the onset of
symptoms. The patients collected the mushrooms from
the nearby mountain, and the mushrooms were carefully
washed before cooking, so the possibility of contamination
with pesticides as a cause of rhabdomyolysis was also ruled
out. Therefore, we concluded that the rhabdomyolysis was
caused by the wild mushroom R subnigricans.The
individual differences in the clinical manifestations of
poisoning among the patients may be related to the
different amounts they ingested. The patient with normal
CK level (patient 6; Table) had consumed the smallest
amount of mushroom.
Examples of rhabdomyolysis caused by wild mush-
room poisoning have been reported rarely worldwide. In
France, large quantities of the wild mushroom
Tricholoma equestre was reported to cause delayed
rhabdomyolysis in 12 patients, 3 of whom died.
10
In
Taiwan, an outbreak of R subnigricans poisoning was
reported, in which 2 patients progressed to rhabdo-
myolysis, and 7 patients recovered in 1 day with
supportive care at home.
8
In a recent report of 183
patients who died of mushroom poisoning from 1994 to
2012 in southern China, 24.59% of the deaths were caused
by R subnigricans. However, whether rhabdomyolysis was
the main cause of death in patients with R subnigricans
poisoning is not known.
2
Herein, we provide further
evidence that fatal rhabdomyolysis may result from wild
mushroom R subnigricans poisoning. Physicians should
be aware of the possibility of severe rhabdomyolysis after
large quantities of R subnigricans have been consumed.
Several toxins have been found in R subnigricans. Six
chlorinated phenyl ethers, designated russuphelins A, B,
C, D, E, and F, were isolated from R subnigricans by
Takahashi et al.
11,12
Russuphelin A was cytotoxic to
various solid tumor cells, and russuphelins B, C, and D
were cytotoxic to P388 leukemia cells in vitro. Recently,
Matsuura et al.
13
isolated the small, highly strained
cycloprop-2-ene carboxylic acid from Asian R subnigri-
cans. This compound was associated with fatal rhabdo-
myolysis in mice. However, whether this carboxylic acid
is also responsible for fatal rhabdomyolysis in humans
remains unknown.
A phalloides is the most toxic mushroom and the
major cause of mortality caused by mushroom ingestion
worldwide. In China, most patients with wild mushroom
poisoning cannot identify the wild mushrooms they
consumed. It is important for physicians to judge quickly
and correctly the potential toxicity of wild mushrooms
from clinical manifestations and initial laboratory exami-
nations to give reasonable and timely treatment.
However, most patients with wild mushroom poisoning
have only gastrointestinal symptoms during the rst
Figure 3. Russula subnigricans mushrooms.
Lin et al382
24 to 48 hours.
14
Therefore, it is currently difcult to
distinguish A phalloides from R subnigricans poisoning.
In the present case study, most of the 7 patients
presented with obvious myalgia and elevated CK on
admission, and their CK levels further increased after
admission. Moreover, although their serum ALT levels
increased after admission, coagulation tests remained
normal. All these clinical features distinguish R
subnigricans from A phalloides poisoning. However,
because some patients with A phalloides poisoning may
also have elevated CK levels,
15
serum CK levels cannot
be used as a denitive way to differentiate R
subnigricans from A phalloides poisoning.
In conclusion, the experience of this group of patients
suggests that clinical presentations of patients with R
subnigricans poisoning can vary from gastrointestinal
symptoms to fatal rhabdomyolysis. Most of the patients
with rhabdomyolysis caused by R subnigricans poison-
ing presented early with myalgia, accompanied by
sustained increase of serum CK. A key to survival for
patients with rhabdomyolysis caused by R subnigricans
poisoning may be early recognition and intensive
supportive care.
References
1. Ahishali E, Boynuegri B, Ozpolat E, et al. Approach to
mushroom intoxication and treatment: can we decrease
mortality? Clin Res Hepatol Gastroenterol. 2012;36:139
145.
2. Chen Z, Zhang P, Zhang Z. Investigation and analysis of
102 mushroom poisoning cases in Southern China from
1994 to 2012. Fungal Divers. 2014;64:123131.
3. Lawton LD, Bhraonain SN. Accidental poisoning by death
cap mushrooms: be careful what you eat. Wilderness
Environ Med. 2013;24:168170.
4. Poucheret P, Fons F, Doré JC, Michelot D, Rapior S.
Amatoxin poisoning treatment decision-making: pharmaco-
therapeutic clinical strategy assessment using multidimen-
sional multivariate statistic analysis. Toxicon. 2010;55:
13381345.
5. Santi L, Maggioli C, Mastroroberto M, Tufoni M, Napoli
L, Caraceni P. Acute liver failure caused by Amanita
phalloides poisoning. Int J Hepatol. 2012:487480.
6. Lima AD, Costa Fortes R, Carvalho Garbi Novaes MR,
Percário S. Poisonous mushrooms: a review of the most
common intoxications. Nutr Hosp. 2012;27:402408.
7. Horn S, Horina JH, Krejs GJ, Holzer H, Ratschek M. End-
stage renal failure from mushroom poisoning with Corti-
narius orellanus: report of four cases and review of the
literature. Am J Kidney Dis. 1997;30:282286.
8. Lee P-T, Wu M-L, Tsai W-J, Ger J, Deng J-F, Chung H-
M. Rhabdomyolysis: an unusual feature with mushroom
poisoning. Am J Kidney Dis. 2001;38:e17.1e17.5.
9. Parekh R, Care DA, Tainter CR. Rhabdomyolysis: advan-
ces in diagnosis and treatment. Emerg Med Pract.
2012;14:115.
10. Bedry R, Baudrimont I, Defeux G, et al. Wild-
mushroom intoxication as a cause of rhabdomyolysis.
N Engl J Med. 2001;345:798802.
11. Takahashi A, Agatsuma T, Ohta T, Nunozawa T, Endo T,
Nozoe S. Russuphelins B, C, D, E and F, new cytotoxic
substances from the mushroom Russula subnigricans
Hongo. Chem Pharm Bull (Tokyo). 1993;41:17261729.
12. Takahashi A, Agatsuma T, Matsuda M, et al. Russuphelin
A, a new cytotoxic substance from the mushroom Russula
subnigricans Hongo. Chem Pharm Bull (Tokyo).
1992;40:31853188.
13. Matsuura M, Saikawa Y, Inui K, et al. Identication of the
toxic trigger in mushroom poisoning. Nat Chem Biol.
2009;5:465467.
14. Kaufmann P. Mushroom poisonings: syndromic diagnosis
and treatment [in German]. Wien Med Wochenschr.
2007;157:493502.
15. Unverir P, Soner BC, Dedeoglu E, Karcioglu O, Boztok K,
Tuncok Y. Renal and hepatic injury with elevated cardiac
enzymes in Amanita phalloides poisoning: a case report.
Hum Exp Toxicol. 2007;26:757761.
Rhabdomyolysis by Russula Mushroom 383
... For example, Lentinus edodes can not only serve as a nutrional supplement but also be used in the treatment of diseases such as depressed immune function and cancer (Sheng et al. 2021;Ahmad et al. 2023). In addition, some macrofungi can synthesize toxins that harm human and/or animal health, such as Amanita exitialis, Russula subnigricans, and Chlorophyllum molybdites (Lin et al. 2015;Sun et al. 2018;Khusairi et al. 2021). On the other hand, toxins produced by some macrofungi have potential medicinal value in the treatment of serious diseases such as cancer (e.g. ...
Article
Full-text available
Macrofungi (or mushrooms) are essential for agriculture, food, and ecology. Although research on the growth and development of macrofungi (GDM) can provide insights into their biological characteristics and metabolite synthesis mechanisms, further exploration is needed for a systematic and visual analysis of the current research progress on GDM. To comprehensively understand the research status and development trend of GDM, a total of 545 scientific literature related to GDM in the Web of Science Core Collection database from 2008 to 2024 were searched and selected as research objects. The general information (publication year, country, institution, and cited journal) and the specific information (co-authorship, keyword co-occurrence, and references with strong citation bursts) were mined and visualized in detail based on CiteSpace software. These analyses demonstrated that related research is still fashionable, and China is dominant and influential in this field. More frequent and in-depth cooperation among authors, institutions and regions is conducive to promoting the research on GDM. Additionally, the quantity and cluster analyses of keywords and references demonstrated that medicinal/edible macrofungi and sustainable development (e.g. mushroom substrate reuse) may be research hotspots and will remain popular in the coming years. This research aims to supply researchers with up-to-date knowledge and cutting-edge issues related to GDM by providing a visually appealing representations on quantitative GDM studies.
... The subgenus Compactae is characterized by the presence of small to large basidiocarps, with the pileus ranging between white, grey, brown to black; whose context turns greyish, reddish to blackish when bruised; with unequal lamellae, tasting mild to acrid, basidiospores devoid of amyloid suprahilar spot and the probable presence of gloeocystidia in all tissues (Buyck et al. 2018). One species of the subgenus, Russula subnigricans Hongo, was described as a lethal poisonous mushroom that exhibited a range of symptoms, including acute renal injury, ventricular tachycardia, hypocalcemia, cardiogenic shock, and rhabdomyolysis, leading to fatalities in certain cases (Lin et al. 2015;Cho and Han 2016;Trakulsrichai et al. 2020;Chun et al. 2023). The aim of this study was to determine the authenticity of a newly discovered Russula species from the Compactae subgenus, which was found in the lateritic area of West Bengal. ...
Article
Full-text available
During extensive field explorations of the Lateritic area in West Bengal, one remarkable wild Russuloid macrofungus, ethnically termed “Kend Patra,” was collected. The species was known to enrich the diet of the local people, being considered as income source for some tribal groups. Using morphological characters and molecular analysis of this collection, provide a unique placement of the taxon in the Russula subgenus Compactae (Fr.) Bon. Further in order to find functional constituents for biopharma applications, methanolic extract was prepared that shows the existence of a substantial amounts of phenol, flavonoid, ascorbic acid and carotenoids. Antioxidant activity was determined where the fraction demonstrated strong DPPH, ABTS, and nitric oxide radical scavenging activities, high Fe²⁺ ion chelating ability, and a reducing power with EC50 values ranging from 538.69 to 891.75 µg/ml. The extract was found to be effective against Listeria monocytogenes, Bacillus subtilis, Pseudomonas aeruginosa, Escherichia coli, Salmonella typhi and Staphylococcus aureus. In addition, the extract exhibited potent anticancer activities as it inhibited A549 cell proliferation, caused morphological changes, elevated ROS levels, hindered the clonogenic ability and migratory potential of cancerous cells, arrested cell cycle progression at S phase, and induced apoptosis by modulating the intrinsic mitochondrial pathway. Overall, this study contributes a new species to the world’s myco-diversity and presents an exciting opportunity for future researchers to conduct comprehensive investigations on this unique species in order to uncover potential new medications for human use.
... 36 Hızlı başlangıçlı Miyotoksisite: Bu alt grupta neden olan toksinin oldukça gergin bir karboksilik asit, sikloprop-2-en karboksilik bir asit olduğu bildirilmiştir. 37 Seçilen Russula spp'nin alınması ile ilişkilidir (R. subnigrans). 38,39 Cyclopropylacetyl-(R)-carnitine, bu tür için benzersiz bir belirteç olarak tanımlanmıştır. ...
... Lin et al. [38] 7 ...
Article
Full-text available
Mushroom is a fungus widely used as an edible in various parts of the world, especially in hilly regions with damp climates. Nevertheless, when picked from the wild to use as a vegetable, it has proved fatal for people ingesting it due to a lack of knowledge for distinguishing between poisonous and non-poisonous mushrooms by the people of the local community. Three cases presented as emergencies from a single household comprising a 13-year-old girl and both her grandparents following the ingestion of mushrooms picked from a nearby forest area. Luckily the parents of the girl were out for work, so they survived and helped identify the mushroom. Most cases are not reported or documented, and data are present mainly in the form of case reports.
Article
Background Mushroom poisoning caused by the ingestion of Russula subnigricans has been reported to cause rhabdomyolysis and cardiac dysfunction, leading to death. There have been few reports of cardiogenic shock induced by mushroom poisoning that was successfully treated using mechanical circulatory support devices. Case Summary A 38-year-old man presented with gastrointestinal symptoms a day after consuming a curry made with forest-collected mushrooms and was admitted with a diagnosis of rhabdomyolysis. Despite appropriate fluid management for severe rhabdomyolysis, the patient experienced anuria and cardiogenic shock with a remarkably reduced left ventricular ejection function, followed by the development of ventricular fibrillation. Mechanical support using Impella CP, veno-arterial extracorporeal membranous oxygenation (VA-ECMO), and continuous haemodiafiltration were administered for cardiogenic shock and severe rhabdomyolysis. His cardiac and renal function gradually improved, and the patient was successfully weaned off VA-ECMO on day 4, Impella CP on day 5, and renal replacement therapy on day 23. The left ventricular ejection fraction returned to normal without any neurological, respiratory, or renal sequelae. The remaining mushroom samples were identified as R. subnigricans by polymerase chain reaction testing. Discussion This is the first reported case of cardiogenic shock caused by R. subnigricans poisoning, successfully treated with Impella CP and VA-ECMO. The optimal use of mechanical circulatory support devices plays an important role in the treatment of cardiogenic shock caused by mushroom toxicity.
Article
Full-text available
We encountered a case of mushroom intoxication complicated by “toxic-like” myocarditis. Because of the lack of systematized knowledge on this subject, we performed a systematic review of the literature on cardiac toxicity in mushroom poisoning (MP). The aim of this study was to identify and describe the severity, the causal relationship, and the mushroom species involved in other reported cardiac events associated with MP. We included 39 studies in our review. We found 106 cases of cardiac events associated with MP, including 18 deaths. A wide variety of cardiac manifestations were reported, ranging from the simple elevation of cardiac enzymes (n = 61) to ventricular tachycardia (n = 14), acute heart failure (n = 18), and myocarditis (n = 7). Causal relationship between cardiac manifestations and mushroom poisoning was assessed for 42 patients, applying the algorithm validated by the French Toxicovigilance Coordination Committee. Twenty-three cases (54.8%) had a “possible” causal relationship, eight cases (19%) a “probable” relationship, and ten cases (23.8%) a “very probable” relationship. Several fungal genera were involved in reported cases, including Amanita but also rarer ones like Russula and Tricholoma. In conclusion, we showed that cases of cardiac toxicity following MP have been documented in the existing literature, and for some of them, we assessed a strong causal relationship.
Article
Introduction: Russula subnigricans is now one of the leading lethal mushroom species in China, with a mortality rate of more than 50%. The typical clinical manifestation of Russula subnigricans poisoning is rhabdomyolysis, and we are unaware of previous reports of Russula subnigricans-associated hemolysis. Case series: Herein we report a cluster of five patients with confirmed Russula subnigricans poisoning. Four of the patients who ingested sun-dried Russula subnigricans never developed rhabdomyolysis. However, in one patient, acute hemolysis developed on the second day following ingestion and was associated with a fall in hemoglobin concentration and a rise in unconjugated bilirubin concentration. Further investigation revealed that the patient had glucose-6-phosphate dehydrogenase deficiency. Conclusion: This case cluster suggests that the toxin of Russula subnigricans could cause hemolysis in a susceptible patient and warrants further study.
Article
Mushroom poisoning is increasing worldwide, as well as the incidence of fatal mushroom poisoning. Several new syndromes associated with mushroom poisoning have been described in the literature. Notably, 1 of the newly identified mushroom poisonings is Russula subnigricans poisoning. R subnigricans can be classified as causing a delayed-onset rhabdomyolytic syndrome as patients with this severe poisoning present with severe rhabdomyolysis, acute kidney injury, and cardiomyopathy. However, there are only a few reports on the toxicity of R subnigricans. We recently treated 6 patients with R subnigricans mushroom poisoning, of whom 2 died. The 2 patients showed severe rhabdomyolysis, metabolic acidosis, acute renal failure, electrolyte imbalance, and irreversible shock, which caused their deaths. Mushroom poisoning should be considered in the evaluation of rhabdomyolysis of unknown origin. In addition, in cases of mushroom poisoning with severe rhabdomyolysis, R subnigricans poisoning should be promptly identified.
Article
Full-text available
Mushroom poisoning is the main cause of mortality in food poisoning incidents in China. Although some responsible mushroom species have been identified, some were identified inaccuratly. This study investigated and analyzed 102 mushroom poisoning cases in southern China from 1994 to 2012, which involved 852 patients and 183 deaths, with an overall mortality of 21.48 %. The results showed that 85.3 % of poisoning cases occurred from June to September, and involved 16 species of poisonous mushroom: Amanita species (A. fuliginea, A. exitialis, A. subjunquillea var. alba, A. cf. pseudoporphyria, A. kotohiraensis, A. neoovoidea, A. gymnopus), Galerina sulciceps, Psilocybe samuiensis, Russula subnigricans, R. senecis, R. japonica, Chlorophyllum molybdites, Paxillus involutus, Leucocoprinus cepaestipes and Pulveroboletus ravenelii. Six species (A. subjunquillea var. alba, A. cf. pseudoporphyria, A. gymnopus, R. japonica, Psilocybe samuiensis and Paxillus involutus) are reported for the first time in poisoning reports from China. Psilocybe samuiensis is a newly recorded species in China. The genus Amanita was responsible for 70.49 % of fatalities; the main lethal species were A. fuliginea and A. exitialis. Russula subnigricans caused 24.59 % of fatalities, and five species showed mortality >20 % (A. fuliginea, A. exitialis, A. subjunquillea var. alba, R. subnigricans and Paxillus involutus). Mushroom poisoning symptoms were classified from among the reported clinical symptoms. Seven types of mushroom poisoning symptoms were identified for clinical diagnosis and treatment in China, including gastroenteritis, acute liver failure, acute renal failure, psychoneurological disorder, hemolysis, rhabdomyolysis and photosensitive dermatitis.
Article
Full-text available
Mushroom poisoning is a relatively rare cause of acute liver failure (ALF). The present paper analyzes the pathogenesis, clinical features, prognostic indicators, and therapeutic strategies of ALF secondary to ingestion of Amanita phalloides, which represents the most common and deadly cause of mushroom poisoning. Liver damage from Amanita phalloides is related to the amanitins, powerful toxins that inhibit RNA polymerase II resulting in a deficient protein synthesis and cell necrosis. After an asymptomatic lag phase, the clinical picture is characterized by gastrointestinal symptoms, followed by the liver and kidney involvement. Amatoxin poisoning may progress into ALF and eventually death if liver transplantation is not performed. The mortality rate after Amanita phalloides poisoning ranges from 10 to 20%. The management of amatoxin poisoning consists of preliminary medical care, supportive measures, detoxification therapies, and orthotopic liver transplantation. The clinical efficacy of any modality of treatment is difficult to demonstrate since randomized, controlled clinical trials have not been reported. The use of extracorporeal liver assist devices as well as auxiliary liver transplantation may represent additional therapeutic options.
Article
Full-text available
Mushrooms have been used as components of human diet and many ancient documents written in oriental countries have already described the medicinal properties of fungal species. Some mushrooms are known because of their nutritional and therapeutical properties and all over the world some species are known because of their toxicity that causes fatal accidents every year mainly due to misidentification. Many different substances belonging to poisonous mushrooms were already identified and are related with different symptoms and signs. Carcinogenicity, alterations in respiratory and cardiac rates, renal failure, rhabidomyolisis and other effects were observed in toxicity studies with various species including edible and therapeutic ones. Proper identification is important to avoid accidents and toxicity studies are necessary to assure the safe use of mushrooms as food and for medicinal purposes.
Article
The major syndromes of mushroom poisoning can be divided by presentation timing: Early syndromes (symptom onset <6 hrs after ingestion) have little probability to cause organ damage. Epigastric pain, nausea, vomiting and diarrhea occur in most cases and treatment includes initial gastrointestinal decontamination with oral activated charcoal and fluid rehydration. In addition, an acute gastrointestinal syndrome can be combined with cholinergic toxicity, epileptiformic response or immuno-hemolytic anemia. Neurotoxic Syndromes may present as dysphoria, delirium, hallucinations or disulfiram-like reactions. Treatment is entirely supportive and if performed in hospital, the prognosis is good. Late syndromes (symptom onset >6 hrs after ingestion) are life-threatening due to liver- and renal failure. Patients who are jaundiced after an acute gastrointestinal episode, are suspected to be poisoned with Amatoxins. Patients with flank pain, hematuria, polyuria or oliguria in the absence of jaundice are suspected to have an intoxication with Cortinarius mushrooms. In both cases an intensive care management is indicated.
Article
Rhabdomyolysis is a potentially life-threatening condition caused by a breakdown of skeletal muscle and the release of the intracellular contents into the circulatory system. There are many possible causes, including crush injury, excessive muscular activity, medications, infections, and varied metabolic, connective tissue, rheumatologic, and endocrine disorders. It is vital that emergency clinicians consider the diagnosis when patients present with circumstances known to be high-risk for rhabdomyolysis, including intoxication, prolonged immobilization, and/or altered mentation. Optimal crystalloid selection is still debated, but immediate, aggressive intravenous volume expansion is indicated to prevent myoglobinuric renal failure. Serum potassium levels must be obtained and electrocardiograms must be evaluated to identify life- and limb-threatening complications of hyperkalemia. This review examines the current evidence on symptoms and diagnostic methods as well as standard first-line treatments of rhabdomyolysis. In addition, evidence from animal models on urine alkalinization with sodium bicarbonate infusion is discussed.
Article
Mushroom is widely consumed in Turkey because it is inexpensive and widely available. Intoxication with mushroom is a common health problem in Turkey with a high mortality rate. To identify the outcome of patients with wild mushroom intoxication who were diagnosed based on systematic criteria and had received a comprehensive treatment. Seventy-seven patients admitted to the Emergency Department of our hospital with mushroom intoxication were retrospectively evaluated. The patients were administered a combined treatment of gastric lavage, activated charcoal, penicillin G, N-acetyl cysteine, silybin and hemofiltration. Demographic, clinical and laboratory data of patients and the outcomes of the treatment modality were recorded. A total of 77 patients, 46 (59.7%) females and 31 (40.3%) males were evaluated in the study. The mean age of the patients was 41.94 ± 15.40 years. They presented with nausea and vomiting within 4 to 48 hours. Sixteen patients (20.7%) had abdominal pain, six patients had (7.7%) diarrhea and five patients (6.5%) had jaundice. Seven patients (9%) developed acute liver failure and were referred to intensive care units. Five of these patients recovered without any liver transplantation; one patient had cadaveric liver transplantation but died in the early period after the transplantation and one patient died while waiting for transplantation. The rest of the patients were followed by us and they all have recovered. Our data indicate that clinical diagnosis based on systematic criteria and a comprehensive treatment regimen may be effective in decreasing the mortality in mushroom intoxication.
Article
We have isolated the small, highly strained carboxylic acid cycloprop-2-ene carboxylic acid from the Asian toxic mushroom Russula subnigricans. This compound is responsible for fatal rhabdomyolysis, a new type of mushroom poisoning that is indicated by an increase in serum creatine phosphokinase activity in mice. We found that polymerization of the compound at high concentrations via ene reaction abolishes its toxicity.
Article
A new cytotoxic substance, designated russuphelin A (1), has been isolated from the mushroom Russula subnigricans Hongo (Basidiomycetes). The structure was elucidated as 2,6-bis(2,6-dichloro-4-hydroxyphenyloxy)-1,4-dimethoxy-benzene on the basis of spectroscopic data and confirmed by total synthesis.